0001127602-19-030039.txt : 20191003 0001127602-19-030039.hdr.sgml : 20191003 20191003172254 ACCESSION NUMBER: 0001127602-19-030039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191001 FILED AS OF DATE: 20191003 DATE AS OF CHANGE: 20191003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burke William P. Mr. CENTRAL INDEX KEY: 0001682069 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 191136662 MAIL ADDRESS: STREET 1: HAEMONETICS CORPORATION STREET 2: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 FORMER NAME: FORMER CONFORMED NAME: Burke Willaim P DATE OF NAME CHANGE: 20160810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0328 BUSINESS ADDRESS: STREET 1: 400 WOOD RD CITY: BRAINTREE STATE: MA ZIP: 02184 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2019-10-01 0000313143 HAEMONETICS CORP HAE 0001682069 Burke William P. Mr. 400 WOOD ROAD BRAINTREE MA 02184 1 EVP, Chief Financial Officer Common Stock 2019-10-01 4 M 0 5718 41.64 A 20178 D Common Stock 2019-10-01 4 S 0 3070 124.47 D 17108 D Common Stock 2019-10-01 4 S 0 1309 125.71 D 15799 D Common Stock 2019-10-01 4 S 0 1670 126.72 D 14129 D Common Stock 2019-10-01 4 S 0 648 127.80 D 13481 D Common Stock 2019-10-01 4 S 0 467 128.66 D 13014 D Non-qualified Stock Option (Right to Buy) 41.64 2019-10-01 4 M 0 5718 0 D 2018-06-06 2024-06-06 Common Stock 5718 11435 D Transaction pursuant to an existing 10b5-1 trading plan. This number includes unvested RSUs previously reported. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.21 to $124.98, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.24 to $126.16, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.29 to $127.18, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.31 to $127.99, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.55 to $129.00, inclusive. Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. /s/ Thomas V. Powers, attorney-in-fact for Mr. Burke 2019-10-03